Have multiple conditions? Click here
You are viewing Clinical Trials In Arizona
Have multiple conditions? Click here

Showing 1-100 of 1146
There are 1146 trials in Arizona
Name City State Zip
Impact of PCV on Disease and Colonization Among Native American Communities Whiteriver AZ
Neoadjuvant Study Investigating Degarelix in Patients Suffering From Prostate Cancer Tuscon AZ 85712
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer Tuscon AZ 85712
ACT-293987 in Pulmonary Arterial Hypertension Tuscon AZ 85704
Effects of a Vitality Dietary Supplement on Physical and Mental Function in Middle-aged Adults Tuscon AZ 85712
Safety and Efficacy of BGS649 in Obese, Hypogonadotropic Hypogonadal Men Tuscon AZ 85712
Time to Eugonadal Range, Time to Steady State and Drying Time Tuscon AZ 85712
Replagal Enzyme Replacement Therapy for Children With Fabry Disease Tucson AZ 85719
Insulin Resistance Intervention After Stroke Trial Tucson AZ 85721
Albumin in Acute Ischemic Stroke Trial Tucson AZ 85721
Behavioral & Nutritional Treatment to Help CF Preschoolers Grow Tucson AZ 85721
Effect of Entecavir in Blacks/African Americans and Hispanics With Chronic Hepatitis B Virus (HBV) Infection Tucson AZ 85721
Phase II Study of the Safety and Efficacy of the Relay Thoracic Stent-Graft Tucson AZ 85721
A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer´s Disease Tucson AZ 85721
Telephone Counseling: Men With Prostate Cancer & Partners Tucson AZ 85721
Safety and Efficacy Study of Several Replagal Dosing Regimens on Cardiac Function in Adults With Fabry Disease Tucson AZ 85721
Collection and Testing of Respiratory Samples Tucson AZ 85721
A Study of Response-Guided Duration of Combination Therapy With GS-9451, Pegasys® and Copegus® With and Without Tegobuvir (GS-9190) in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C Tucson AZ 85721
Safety Trial of Single Versus Multiple Dose Thymoglobulin Induction in Kidney Transplantation Tucson AZ 85721
A Trial of Group Psychotherapy for Veterans and Military Personnel With Post Traumatic Stress Disorder (PTSD) Tucson AZ 85721
A Clinical Study of the Safety and Efficacy of the Relay Thoracic Stent-Graft in Patients With Thoracic Aortic Pathologies Tucson AZ 85721
Emergency Preservation and Resuscitation (EPR) for Cardiac Arrest From Trauma Tucson AZ 85721
I-SPY 2 TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer Tucson AZ 85721
The Study of Soy Isoflavones in Asthma Tucson AZ 85721
SciBase International Melanoma Pivotal Study Tucson AZ 85721
PRE-DETERMINE Cohort Study Tucson AZ 85721
Study of Asthma and Nasal Steroids Tucson AZ 85721
Effect of Adaptive Servo Ventilation (ASV) on Survival and Hospital Admissions in Heart Failure Tucson AZ 85721
A Study to Evaluate the Efficacy and Safety of CEP-33457 in Patients With Systemic Lupus Erythematosus Tucson AZ 85721
Study of the Safety and Efficacy of TH-302 in Combination With Gemcitabine Compared With Gemcitabine Alone in Previously Untreated Patients With Pancreatic Adenocarcinoma Tucson AZ 85721
Multifamily Psychoeducation and Cognitive Remediation for Recent-Onset Psychosis Tucson AZ 85721
Instant Total Contact Cast to Heal Diabetic Foot Ulcers Tucson AZ 85721
Buprenorphine and Integrated HIV Care Evaluation Tucson AZ 85745
Both Exercise and Adenosine Stress Testing Tucson AZ 85715
Removal Versus Retention of Cerclage in Preterm Premature Rupture of Membranes (PPROM) Tucson AZ 85712
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery Tucson AZ 85712
Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery Tucson AZ 85712
Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial Tucson AZ 85723
Genetic Study of Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Multiple Myeloma Tucson AZ 85723
Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases Tucson AZ 85723
Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma Tucson AZ 85723
Safety and Efficacy Study of ICXP007 With Compression Bandaging for the Treatment of Non-Infected Venous Leg Ulcers Tucson AZ 85723
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Tucson AZ 85723
Randomized On-X Anticoagulation Trial Tucson AZ 85723
Pancreatic Cancer Serum and DNA Repository Tucson AZ 85723
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery Tucson AZ 85723
Safety and Efficacy Study of an Interactive Wound Dressing (KC002) for the Treatment of Diabetic Foot Ulcers Tucson AZ 85723
A Pilot Study of Effect of Dexmedetomidine on Sleep and Inflammation in Critically Ill Patients Tucson AZ 85723
Using the Internet to Collect Symptoms and the Ability to Carry Out Daily Activities From Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy Tucson AZ 85723
Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer Tucson AZ 85723
Welchol as Monotherapy for Type 2 Diabetes Mellitus Tucson AZ 85723
Eszopiclone and Inflammatory Mediators in Patients With Acute Coronary Syndrome Tucson AZ 85723
Impact of Accu-Chek 360 in Veterans With Type 2 Diabetes Tucson AZ 85723
Evaluation of VA's Traumatic Brain Injury (TBI) Clinical Reminder and Comprehensive TBI Evaluation Tucson AZ 85723
Colonic Transit Time Validation Study Tucson AZ 85723
Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement Tucson AZ 85723
Extended Steroid in CAP(e) Tucson AZ 85723
Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes Tucson AZ 85723
Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer Tucson AZ 85723
A Trial of Group Psychotherapy for Veterans and Military Personnel With Post Traumatic Stress Disorder (PTSD) Tucson AZ 85723
Sleep Intervention During Acute Lung Injury Tucson AZ 85723
A Study Evaluating the Clinical Benefit of Adding Custirsen to Docetaxel Retreatment/Prednisone as Second Line Therapy in Men With Castrate Resistant Prostate Cancer (CRPC) Tucson AZ 85723
Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer Tucson AZ 85723
Effect of Esomeprazole 40 mg.Daily for 7 Days on Acid Reflux and Related Arousals During Sleep in Patients With GERD Tucson AZ 85723
Drug-Eluting Stents vs. Bare Metal Stents In Saphenous Vein Graft Angioplasty Tucson AZ 85723
Effect of Rozerem on the Perception of GERD Symptoms in Patients With Chronic Insomnia. Tucson AZ 85723
The Effect of High PCO2 Solution on Esophageal Acid Sensation Tucson AZ 85723
Comparison of Nexium VS. Secretol in the Healing and Controlling of Symptoms in GERD Patients With Severe EE. Tucson AZ 85723
Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment Tucson AZ 85723
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy Tucson AZ 85723
A Pilot Study of CPAP Adherence Promotion by Peer Buddies With Sleep Apnea Tucson AZ 85723
UT-15C SR in the Treatment of Critical Limb Ischemia Tucson AZ 85704
Gemzar, Cisp, Sunitinib Urothelial Ca Tucson AZ 85745
Efficacy and Safety of MORAb-003 in Subjects With Platinum-sensitive Ovarian Cancer in First Relapse Tucson AZ 85745
A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer Tucson AZ 85745
ARQ 197 Plus Erlotinib Versus Placebo Plus Erlotinib for the Treatment of Non-squamous, Non-small-cell Lung Cancer Tucson AZ 85745
Welchol as Monotherapy for Type 2 Diabetes Mellitus Tucson AZ 85741
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) Tucson AZ 85741
Cartilage Autograft Implantation System (CAIS) for the Repair of Knee Cartilage Through Cartilage Regeneration Tucson AZ 85713
Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder Tucson AZ 85710
Sleep Intervention During Acute Lung Injury Tucson AZ 85721
Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes Tucson AZ
Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer Tucson AZ 85712
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer Tucson AZ 85712
Randomized Trial of Fulvestrant With or Without Dasatinib in Men and Postmenopausal Women Who Have Hormone Receptor-positive Advanced Breast Cancer Previously Treated With an Aromatase Inhibitor Tucson AZ 85704
Safety Study of ABT-263 in Combination With Rituximab in Lymphoid Cancers Tucson AZ 85724
Welchol as Monotherapy for Type 2 Diabetes Mellitus Tucson AZ 85705
Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer Tucson AZ 85719
Studying Biomarkers in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells Tucson AZ 85719
A Study to Investigate the Safety and Efficacy of AT13387, Alone or in Combination With Imatinib, in Patients With GIST Tucson AZ 85719
Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Tucson AZ 85719
Efficacy Study for AC220 to Treat Acute Myeloid Leukemia (AML) Tucson AZ 85719
A Study of the HSP90 Inhibitor, STA-9090 in Subjects With Stage IIIB or IV Non-Small Cell Lung Cancer (NSCLC) Tucson AZ 85719
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy Tucson AZ 85719
Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer Tucson AZ 85719
Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer Tucson AZ 85719
Isotretinoin With or Without Monoclonal Antibody, Interleukin-2, and Sargramostim Following Stem Cell Transplantation in Treating Patients With Neuroblastoma Tucson AZ 85724
Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma Tucson AZ 85724
Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma Tucson AZ 85724
Selenium for Prevention of Adenomatous Colorectal Polyps Tucson AZ 85724
View Clinical Trial Facilities in Arizona

Showing 1-100 of 1146
Alabama - Alaska - Arizona - Arkansas - California - Colorado - Connecticut - Delaware - Washington DC - Florida - Georgia - Hawaii - Idaho - Illinois - Indiana - Iowa - Kansas - Kentucky - Louisiana - Maine - Maryland - Massachusetts - Michigan - Minnesota - Mississippi - Missouri - Montana - Nebraska - Nevada - New Hampshire - New Jersey - New Mexico - New York - North Carolina - North Dakota - Ohio - Oklahoma - Oregon - Pennsylvania - Rhode Island - South Carolina - South Dakota - Tennessee - Texas - Utah - Vermont - Virginia - Washington - West Virginia - Wisconsin - Wyoming
For Sponsors: Promote Your Study | For Research Sites: Promote Your Site

Copyright 2012 Clinical Trials Institute, LLC | All Rights Reserved
Login
Forgot password?
Enter your email and we will resend your password
Register